ZUBEREITUNGEN ENTHALTEND DOMPERIDON

Patent europeic · EP3681502 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3681502
Numer da la dumonda
EP19802016
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-10-2019
Publitgà
22-07-2020
Concedì
17-03-2021
Stritgà
25-05-2023
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/454 (2006.01)
A61P 1/08 (2006.01)
Prioritad
US 201862750480 P 25.10.2018
Dumonda PCT
PCT/US2019/058037 25.10.2019
Publicaziun PCT
WO2020/086950 30.04.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-05-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.05.2023

  2. 26-01-2022

    Midada

    Published in Swissreg on 26.01.2022

  3. 17-03-2021

    Concedì

    Published in Swissreg on 17.03.2021

Partidas

Possessur

CinDome Pharma, Inc.

5375 Medpace Way, Cincinnati, OH 45227, US

Inventur

ISAACSOHN, Jonathan

Cincinnati, Ohio 45237, US

PATEL, Piyush

Garnet Valley, Pennsylvania 19060, US

PEARCE, Catherine

Montgomery, Ohio 45242, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.